Target intelligence / Profile preview

Neutrophil extracellular trap DNA (NET DNA)

Target
NET DNA
Molecular classification
Other (extracellular chromatin/DNA-protein complex)
01

Overview

Neutrophil extracellular trap DNA is the decondensed chromatin released from activated neutrophils as part of NETs, which are web-like extracellular structures composed primarily of DNA, histones, and antimicrobial proteins. These structures trap and kill pathogens in the extracellular space and contribute to immune defense but are also implicated in inflammatory diseases, autoimmunity, thrombosis, and cancer. The DNA backbone of NETs is directly antimicrobial and acts as a scaffold for associated proteins. Excess NETs or impaired clearance can drive pathology through inflammation, tissue damage, vessel occlusion, and the induction of autoantibodies[1][3][5][7][9].

Other names
NET DNANETs chromatinchromatin of neutrophil extracellular trapsdecondensed NET DNAextracellular neutrophil DNA
02

Mechanism of action

Degradation of extracellular DNA (by DNase) to dissolve NETs and reduce their pathogenic effects; Inhibition of chromatin decondensation and histone modification (by PAD4 inhibitors); Suppression of NET formation (colchicine, chloroquine)

03

Biological functions

Immune response (traps and immobilizes pathogens, facilitates antimicrobial activity)Inflammation (can drive sterile inflammation)Autoantibody production (when dysregulated, can trigger autoimmunity)Thrombosis (contributes to immunothrombosis)Cellular signaling (when DNA acts as a danger-associated molecular pattern)
04

Disease associations

InfectionInflammationAutoimmune disease (e.g., systemic lupus erythematosus)Thrombosis and coagulation disordersCancer (roles in tumor progression and metastasis)Cardiovascular disease
05

Safety considerations

Excessive NET degradation may reduce host defense against pathogensInhibition of NETs may imbalance immune responses, possibly affecting infection controlRisk of provoking or exacerbating autoimmunity if NETs are not cleared effectively
06

Interacting drugs

DNase I (recombinant forms such as dornase alfa)

3 more in the full profile.

07

Biomarkers

Circulating NET DNA (cell-free NET-associated DNA in blood/serum)Citrullinated histone H3Myeloperoxidase-DNA complexesNeutrophil elastase-DNA complexes

Beyond the preview

Go deeper on Neutrophil extracellular trap DNA (NET DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neutrophil extracellular trap DNA (NET DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call